Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2013 by European Organisation for Research and Treatment of Cancer - EORTC.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
Italian Sarcoma Group
UNICANCER
Grupo Espanol de Investigacion en Sarcomas
Information provided by (Responsible Party):
European Organisation for Research and Treatment of Cancer - EORTC
ClinicalTrials.gov Identifier:
NCT00103168
First received: February 7, 2005
Last updated: October 28, 2013
Last verified: October 2013